Rezolute (RZLT) Retained Earnings (2011 - 2026)
Rezolute (RZLT) reported Retained Earnings of -$461.0 million for Q1 2026, down 21.47% on a YoY basis from -$587.0 million in Q1 2025, and down 980846.81% sequentially from $47000.0 in Q4 2025.
Rezolute (RZLT) Retained Earnings (2011 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Retained Earnings data on file, last reported at -$461.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 21.47% year-over-year to -$461.0 million; the trailing twelve-month figure through Mar 2026 stood at -$461.0 million (down 21.47% YoY), and the FY2025 full-year result was $565.9 million, up 716432.91% from the prior year.
- Retained Earnings retreated to -$461.0 million in Q1 2026, from $47000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $569.0 million in Q3 2025 to a low of -$461.0 million in Q1 2026.
- A 5-year average of -$40.5 million and a median of -$219.0 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 716432.91% in 2025, while the deepest fall reached 200.56% in 2025.
- Tracing RZLT's Retained Earnings over 5 years: stood at -$232.6 million in 2022, then slipped by 24.43% to -$289.4 million in 2023, then dropped by 24.6% to -$360.6 million in 2024, then surged by 100.01% to $47000.0 in 2025, then plunged by 980846.81% to -$461.0 million in 2026.
- Business Quant data shows RZLT's Retained Earnings at -$461.0 million in Q1 2026, $47000.0 in Q4 2025, and $569.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | -460.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -460.95 Mn |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 569.03 Mn |
| Jun 30, 2025 | 565.90 Mn |
| Mar 31, 2025 | -379.47 Mn |
| Dec 31, 2024 | -360.60 Mn |
| Sep 30, 2024 | -344.80 Mn |
| Jun 30, 2024 | -79,000.00 |
| Mar 31, 2024 | 377.37 Mn |
| Dec 31, 2023 | -289.40 Mn |
| Sep 30, 2023 | -275.51 Mn |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | -248.26 Mn |
| Dec 31, 2022 | -232.59 Mn |
| Sep 30, 2022 | -219.00 Mn |
| Jun 30, 2022 | 358.64 Mn |
| Mar 31, 2022 | 251.67 Mn |
| Dec 31, 2021 | -188.57 Mn |
| Sep 30, 2021 | -176.00 Mn |
| Jun 30, 2021 | 194.23 Mn |